회원 정보팀

빌게이츠 재단 지원 CEPI, 이노비오에 $5,600만 달러 지원결정

2018-04-12 09:01

빌게이츠 재단 지원 CEPI, 이노비오에 $5,600만 달러 지원결정

**진원생명과학 ( 011000)

Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS
https://globenewswire.com/news-release/2018/04/11/1468470/0/en/Inovio-Awarded-up-to-56-Million-from-CEPI-to-Advance-DNA-Vaccines-Against-Lassa-Fever-and-MERS.html
CEPI will fund up to $56,000,000 to support Inovio’s pre-clinical and clinical advancement through Phase 2 of INO-4500, its Lassa fever vaccine, and INO-4700, its MERS vaccine. The shared goal of Inovio and CEPI is for the Lassa and MERS vaccines to be available as soon as possible for emergency use.

To date, CEPI has received multi-year funding from Norway, Germany, Japan, the Bill & Melinda Gates Foundation and Wellcome.

2
0
0
투표를 통해 글쓴이의 랭킹이 변동됩니다.
신중한 투표를 부탁드립니다.
  • 댓글
  • 조회수 94